Newbridge Financial Services Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,340
| Closed | -$42.7K | – | 1366 |
|
|
2025
Q1 | $42.7K | Buy |
9,340
+7,688
| +465% | +$35.1K | 0.01% | 399 |
|
|
2024
Q4 | $9.32K | Buy |
1,652
+1,400
| +556% | +$7.9K | ﹤0.01% | 751 |
|
|
2024
Q3 | $1.22K | Sell |
252
-310
| -55% | -$1.5K | ﹤0.01% | 587 |
|
|
2024
Q2 | $2.74K | Sell |
562
-100
| -15% | -$488 | ﹤0.01% | 921 |
|
|
2024
Q1 | $8.79K | Sell |
662
-1,520
| -70% | -$20.2K | ﹤0.01% | 802 |
|
|
2023
Q4 | $30.4K | Buy |
+2,182
| New | +$30.4K | 0.01% | 509 |
|